Acceleron Pharma competitive analysis

Latest publications and patents of Acceleron Pharma New

Explore the latest publications and patents granted to Acceleron Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Acceleron Pharma

Jun 12, 2024Methods And Compositions For Treating MyelofibrosisGranted And Under Opposition
Mar 27, 2024Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasGranted And Under Opposition
Dec 20, 2023Methods For Treating Eye DisordersGranted And Under Opposition
Mar 10, 2021Compositions For Treating MyelofibrosisNo Opposition Filed Within Time Limit

Explore Acceleron Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 12, 2024Methods And Compositions For Treating Myelofibrosis2
Mar 27, 2024Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias1
Dec 20, 2023Methods For Treating Eye Disorders1

Latest PTAB cases involving Acceleron Pharma

Discover the latest PTAB cases involving Acceleron Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Acceleron Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ACCELERON PHARMA - 4 - - Non-Active
MAIWALD132 - - - Highly Aggressive
WUESTHOFF & WUESTHOFF11 - - - Highly Aggressive
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB33 - - - Highly Aggressive